Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

35.75
Delayed Data
As of May 26
 +1.60 / +4.69%
Today’s Change
17.25
Today|||52-Week Range
36.05
+41.58%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 35.50, with a high estimate of 45.00 and a low estimate of 30.00. The median estimate represents a -0.70% decrease from the last price of 35.75.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.26
Sales
$67.2M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 38.95%
 
 
 
 
 
 
Growthannually -37.05%
 
 
 
 
 
 

Sales

Growthquarterly 16.73%
 
 
 
 
 
 
Growthannually 30.02%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.